FLC Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
FLC Capital Advisors's GILD Position: Q2 2026 in Review
FLC Capital Advisors increased its Gilead Sciences (GILD) stake by 3.7% in Q2 2026, buying an estimated $13.2K and bringing the position to 2,796 shares worth $353K. The position accounts for 0.06% of the portfolio, ranked #168.
FLC Capital Advisors first reported a position in GILD in Q3 2020 and has held it in 23 quarters since. The position peaked at $821K in Q2 2021. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- FLC Capital Advisors held 2,796 shares of Gilead Sciences worth $353K as of Q2 2026.
- FLC Capital Advisors bought 100 Gilead Sciences shares in Q2 2026, an estimated $13.2K.
- Gilead Sciences made up 0.06% of FLC Capital Advisors's portfolio in Q2 2026, its #168 holding.
- FLC Capital Advisors first reported a position in Gilead Sciences in Q3 2020 and has held it in 23 quarters since.
- FLC Capital Advisors's Gilead Sciences position peaked at $821K in Q2 2021.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on FLC Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.